Bladder Cancer

Latest News

Dr. Guerrero-Ramos on the evolving treatment landscape in NMIBC
Dr. Guerrero-Ramos on the evolving treatment landscape in NMIBC

July 18th 2024

"In the last decade, we've observed a high number of new alternatives within clinical trials, especially with intravesical delivery," says Félix Guerrero-Ramos, MD, PhD, FEBU.

IDE397 shows promise in MTAP-deletion urothelial carcinoma
IDE397 shows promise in MTAP-deletion urothelial carcinoma

July 8th 2024

Trial launches of MAT2A inhibitor plus sacituzumab govitecan in bladder cancer
Trial launches of MAT2A inhibitor plus sacituzumab govitecan in bladder cancer

June 26th 2024

Adding durvalumab to chemotherapy extends survival in MIBC
Adding durvalumab to chemotherapy extends survival in MIBC

June 25th 2024

Subcutaneous nivolumab under review in EU for solid tumor indications
Subcutaneous nivolumab under review in EU for solid tumor indications

June 21st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.